244 related articles for article (PubMed ID: 33117288)
21. [Anti-Müllerian hormone as a new marker of the ovarian reserve function preservation by goserelin during (neo)adjuvant chemotherapy for young breast cancer patients].
Wang SY; Wang S
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):536-541. PubMed ID: 31209428
[TBL] [Abstract][Full Text] [Related]
22. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
Broer SL; Broekmans FJ; Laven JS; Fauser BC
Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
[TBL] [Abstract][Full Text] [Related]
23. Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.
Su HI; Kwan B; Whitcomb BW; Shliakhsitsava K; Dietz AC; Stark SS; Martinez E; Sluss PM; Sammel MD; Natarajan L
J Clin Endocrinol Metab; 2020 Aug; 105(8):2740-51. PubMed ID: 32270202
[TBL] [Abstract][Full Text] [Related]
24. Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.
Rodgers RJ; Abbott JA; Walters KA; Ledger WL
Front Endocrinol (Lausanne); 2021; 12():689532. PubMed ID: 34557157
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer.
Anderson RA; Kelsey TW; Perdrix A; Olympios N; Duhamel O; Lambertini M; Clatot F
Breast Cancer Res Treat; 2022 Apr; 192(2):273-282. PubMed ID: 34997365
[TBL] [Abstract][Full Text] [Related]
26. A putative role for anti-Müllerian hormone (AMH) in optimising ovarian reserve expenditure.
Pankhurst MW
J Endocrinol; 2017 Apr; 233(1):R1-R13. PubMed ID: 28130407
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
28. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
Nelson SM; Davis SR; Kalantaridou S; Lumsden MA; Panay N; Anderson RA
Hum Reprod Update; 2023 May; 29(3):327-346. PubMed ID: 36651193
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
[TBL] [Abstract][Full Text] [Related]
30. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
[TBL] [Abstract][Full Text] [Related]
31. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
32. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
33. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients.
Bozza C; Puglisi F; Lambertini M; Osa EO; Manno M; Del Mastro L
Endocr Relat Cancer; 2014 Feb; 21(1):R51-65. PubMed ID: 24292601
[TBL] [Abstract][Full Text] [Related]
34. Accelerated ovarian reserve depletion in female anti-Müllerian hormone knockout mice has no effect on lifetime fertility†.
Guo R; Pankhurst MW
Biol Reprod; 2020 Apr; 102(4):915-922. PubMed ID: 31837140
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
36. Ovarian function, fertility and reproductive lifespan in cancer patients.
Jayasinghe YL; Wallace WHB; Anderson RA
Expert Rev Endocrinol Metab; 2018 May; 13(3):125-136. PubMed ID: 30058903
[TBL] [Abstract][Full Text] [Related]
37. What does anti-Müllerian hormone tell you about ovarian function?
Anderson RA
Clin Endocrinol (Oxf); 2012 Nov; 77(5):652-5. PubMed ID: 22640495
[TBL] [Abstract][Full Text] [Related]
38. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
Moolhuijsen LME; Visser JA
J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
[TBL] [Abstract][Full Text] [Related]
39. Prediction of postchemotherapy ovarian function using markers of ovarian reserve.
Henry NL; Xia R; Schott AF; McConnell D; Banerjee M; Hayes DF
Oncologist; 2014 Jan; 19(1):68-74. PubMed ID: 24319018
[TBL] [Abstract][Full Text] [Related]
40. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
